183 related articles for article (PubMed ID: 29460640)
1. Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions.
Sullivan A; Watkinson J; Waddington J; Park BK; Naisbitt DJ
Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):261-274. PubMed ID: 29460640
[TBL] [Abstract][Full Text] [Related]
2. Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions.
Illing PT; Mifsud NA; Purcell AW
Curr Opin Immunol; 2016 Oct; 42():31-40. PubMed ID: 27261882
[TBL] [Abstract][Full Text] [Related]
3. [Genetic predispositions in drug allergy: the role of HLA].
Bergmann MM; Villard J; Caubet JC
Rev Med Suisse; 2014 Apr; 10(426):864-8. PubMed ID: 24834645
[TBL] [Abstract][Full Text] [Related]
4. Delayed drug hypersensitivity: models of T-cell stimulation.
Adam J; Pichler WJ; Yerly D
Br J Clin Pharmacol; 2011 May; 71(5):701-7. PubMed ID: 21480949
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms leading to T-cell activation in drug hypersensitivity.
Meng X; Yerly D; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):317-324. PubMed ID: 29905574
[TBL] [Abstract][Full Text] [Related]
6. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
[TBL] [Abstract][Full Text] [Related]
7. T cell-mediated hypersensitivity reactions to drugs.
Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
[TBL] [Abstract][Full Text] [Related]
8. Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.
Deshpande P; Hertzman RJ; Palubinsky AM; Giles JB; Karnes JH; Gibson A; Phillips EJ
Clin Pharmacol Ther; 2021 Sep; 110(3):607-615. PubMed ID: 34143437
[TBL] [Abstract][Full Text] [Related]
9. Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity.
Faulkner L; Gibson A; Sullivan A; Tailor A; Usui T; Alfirevic A; Pirmohamed M; Naisbitt DJ; Kevin Park B
Toxicol Sci; 2016 Dec; 154(2):416-429. PubMed ID: 27637899
[TBL] [Abstract][Full Text] [Related]
10. Immune dysregulation increases the incidence of delayed-type drug hypersensitivity reactions.
Naisbitt DJ; Olsson-Brown A; Gibson A; Meng X; Ogese MO; Tailor A; Thomson P
Allergy; 2020 Apr; 75(4):781-797. PubMed ID: 31758810
[TBL] [Abstract][Full Text] [Related]
11. HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.
Ogese MO; Saide K; Faulkner L; Whitaker P; Peckham D; Alfirevic A; Baker DM; Sette A; Pirmohamed M; Park BK; Naisbitt DJ
Clin Exp Allergy; 2015 Aug; 45(8):1305-16. PubMed ID: 25851465
[TBL] [Abstract][Full Text] [Related]
12. HLA and Delayed Drug-Induced Hypersensitivity.
Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
[TBL] [Abstract][Full Text] [Related]
13. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
[TBL] [Abstract][Full Text] [Related]
14. Role of T cells in non-immediate drug allergy reactions.
Gómez E; Ruano M; Somoza ML; Fernández J; Blanca-López N
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):294-301. PubMed ID: 31135394
[TBL] [Abstract][Full Text] [Related]
15. Immune pathomechanism of drug hypersensitivity reactions.
Pichler WJ; Naisbitt DJ; Park BK
J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S74-81. PubMed ID: 21354503
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.
Büyüköztürk S; Kekik Ç; Gökyiğit AZ; Tezer Filik FI; Karakaya G; Saygi S; Dursun AB; Kirbaş S; Tüfekçi A; Sin AZ; Aydoğdu I; Sorgun MH; Aydin N; Gelincik A; Çolakoğlu B; Çelik G; Oğuz F
Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):36-41. PubMed ID: 29350020
[No Abstract] [Full Text] [Related]
18. Pharmacogenetics of hypersensitivity drug reactions.
Negrini S; Becquemont L
Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
[TBL] [Abstract][Full Text] [Related]
19. Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01.
Zhao Q; Alhilali K; Alzahrani A; Almutairi M; Amjad J; Liu H; Sun Y; Sun L; Zhang H; Meng X; Gibson A; Ogese MO; Kevin Park B; Liu J; Ostrov DA; Zhang F; Naisbitt DJ
Allergy; 2019 Aug; 74(8):1533-1548. PubMed ID: 30844087
[TBL] [Abstract][Full Text] [Related]
20. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
Pirmohamed M; Ostrov DA; Park BK
J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
